{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-038279","form_type":"8-K","ticker":"MIRA","cik":"0001904286","company_name":"MIRA PHARMACEUTICALS, INC.","filed_at":"2023-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.364828+00:00","generated_at":"2026-06-09T11:49:03.248875+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"MIRA Pharmaceuticals appoints Brian Daly to Board, David Vorhoff resigns","bullets":["Brian Daly appointed to Board of Directors on October 25, 2023.","Daly named Audit Committee Chair and Compensation Committee member.","David Vorhoff resigned from Board on October 19, 2023, with no disagreements.","Daly brings over 30 years of Wall Street experience; currently Managing Partner at Dalglish Investment Holdings."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-038279","json":"https://secwatch.observer/filing/0001493152-23-038279.json","markdown":"https://secwatch.observer/filing/0001493152-23-038279.md","text":"https://secwatch.observer/filing/0001493152-23-038279.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1904286/000149315223038279/0001493152-23-038279-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1904286/000149315223038279/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T11:49:03.248875+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e2705e922","claim":"David Vorhoff resigned as Director at MIRA PHARMACEUTICALS, INC..","evidence_excerpt":"Also, on October 19, 2023, David Vorhoff, resigned from the Board of Directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315223038279/0001493152-23-038279-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"776b8cc925","claim":"Brian Daly was appointed as Director at MIRA PHARMACEUTICALS, INC..","evidence_excerpt":"On October 25, 2023, the Board of Directors (the “Board”) of MIRA Pharmaceuticals, Inc. (the “Company”) unanimously approved the election and appointment of Mr. Brian Daly to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315223038279/0001493152-23-038279-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}